Wells Samuel A, Asa Sylvia L, Dralle Henning, Elisei Rossella, Evans Douglas B, Gagel Robert F, Lee Nancy, Machens Andreas, Moley Jeffrey F, Pacini Furio, Raue Friedhelm, Frank-Raue Karin, Robinson Bruce, Rosenthal M Sara, Santoro Massimo, Schlumberger Martin, Shah Manisha, Waguespack Steven G
1Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
2Department of Pathology, University Health Network, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335.
The American Thyroid Association appointed a Task Force of experts to revise the original Medullary Thyroid Carcinoma: Management Guidelines of the American Thyroid Association.
The Task Force identified relevant articles using a systematic PubMed search, supplemented with additional published materials, and then created evidence-based recommendations, which were set in categories using criteria adapted from the United States Preventive Services Task Force Agency for Healthcare Research and Quality. The original guidelines provided abundant source material and an excellent organizational structure that served as the basis for the current revised document.
The revised guidelines are focused primarily on the diagnosis and treatment of patients with sporadic medullary thyroid carcinoma (MTC) and hereditary MTC.
The Task Force developed 67 evidence-based recommendations to assist clinicians in the care of patients with MTC. The Task Force considers the recommendations to represent current, rational, and optimal medical practice.
美国甲状腺协会任命了一个专家特别工作组,以修订最初的《甲状腺髓样癌:美国甲状腺协会管理指南》。
特别工作组通过系统的PubMed检索确定相关文章,并辅以其他已发表的材料,然后制定基于证据的建议,这些建议使用了改编自美国医疗保健研究与质量机构预防服务工作组的标准进行分类。原始指南提供了丰富的源材料和出色的组织结构,为当前修订后的文件奠定了基础。
修订后的指南主要侧重于散发性甲状腺髓样癌(MTC)和遗传性MTC患者的诊断和治疗。
特别工作组制定了67条基于证据的建议,以协助临床医生护理MTC患者。特别工作组认为这些建议代表了当前合理且最佳的医疗实践。